Helicobacter pylori and Nonmalignant Diseases

Helicobacter

Volumn 18, Issue S1, 2013, Pages 24-27

  den Hollander, Wouter J ^a   Sostres, Carlos ^b   Kuipers, Ernst J ^a   Lanas, Angel ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Allergy; Asthma; Functional dyspepsia; Gastroesophageal reflux disease; Peptic ulcer disease

Indexed keywords

ACETYLSALICYLIC ACID; DOMPERIDONE; GHRELIN; HERBACEOUS AGENT; RIKKUNSHITO; UNCLASSIFIED DRUG;

ALLERGY; ANTICOAGULANT THERAPY; ARTICLE; ASTHMA; DISEASES; DYSPEPSIA; ERADICATION THERAPY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HELICOBACTER PYLORI; HORMONE BLOOD LEVEL; HUMAN; NONHUMAN; NONMALIGNANT DISEASE; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS;

ALLERGY; ASTHMA; FUNCTIONAL DYSPEPSIA; GASTROESOPHAGEAL REFLUX DISEASE; PEPTIC ULCER DISEASE;

ANIMALS; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 84883770933     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12074     Document Type: Article

References (28)

1. Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther 2009;29:938-46.
2. Wang AY, Peura DA. The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world. Gastrointest Endosc Clin N Am 2011;21:613-35.
3. Sanchez-Delgado J, Gene E, Suarez D, Garcia-Iglesias P, Brullet E, Gallach M, et al. Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression. Am J Gastroenterol 2011;106:398-405.
4. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002;359:14-22.
5. Sostres C, Lanas A. Epidemiology and demographics of upper gastrointestinal bleeding: prevalence, incidence, and mortality. Gastrointest Endosc Clin N Am 2011;21:567-81.
6. Gisbert JP, Calvet X, Cosme A, Almela P, Feu F, Bory F, et al. Long-term follow-up of 1, 000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding. Am J Gastroenterol 2012;107:1197-204.
7. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-64.
8. Chan FK, Ching JY, Suen BY, Tse YK, Wu JC, Sung JJ. Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users. Gastroenterology 2013;144:528-35.
9. Saad AM, Choudhary A, Bechtold ML. Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials. Scand J Gastro-enterol 2012;47:129-35.
10. Hirata K, Suzuki H, Matsuzaki J, Masaoka T, Saito Y, Nishizawa T, et al. Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy. J Clin Biochem Nutr 2013;52:172-8.
11. Ashktorab H, Entezari O, Nouraie M, Dowlati E, Frederick W, Woods A, et al. Helicobacter pylori protection against reflux esophagitis. Dig Dis Sci 2012;57:2924-8.
12. Polat FR, Polat S. The effect of Helicobacter pylori on gastroesophageal reflux disease. JSLS 2012;16:260-3.
13. Peters FT, Kuipers EJ, Ganesh S, Sluiter WJ, Klinkenberg-Knol EC, Lamers CB, et al. The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy. Aliment Pharmacol Ther 1999;13:921-6.
14. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-79.
15. Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P. Effect of dyspepsia on survival: a longitudinal 10-year follow-up study. Am J Gastroenterol 2012;107:912-21.
16. Sugano K. Should we still subcategorize Helicobacter pylori-associated dyspepsia as functional disease? J Neurogastroenterol Motil 2011;17:366-71.
17. Suzuki H, Nishizawa T, Hibi T. Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia? J Gastroenterol Hepatol 2011;26(Suppl 3):42-5.
18. Suzuki H, Moayyedi P. Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013;10:168-74.
19. Isomoto H, Ueno H, Saenko VA, Mondal MS, Nishi Y, Kawano N, et al. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. Am J Gastroenterol 2005;100:1711-20.
20. Deng ZH, Chu B, Xu YZ, Zhang B, Jiang LR. Influence of Helicobacter pylori infection on ghrelin levels in children. World J Gastroenterol 2012;18:5096-100.
21. Arai M, Matsumura T, Tsuchiya N, Sadakane C, Inami R, Suzuki T, et al. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology 2012;59:62-6.
22. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006:CD002096.
23. Wu JC. Asian consensus report on functional dyspepsia: necessary and ready? J Gastroenterol Hepatol 2012;27:624-5.
24. Sodhi JS, Javid G, Zargar SA, Tufail S, Shah A, Khan B, et al. Prevalence of Helicobacter pylori infection and the effect of its eradication on symptoms of functional dyspepsia in Kashmir, India. J Gastroenterol Hepatol 2013;28:808-13.
25. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009;7:887-94.
26. Taube C, Muller A. The role of Helicobacter pylori infection in the development of allergic asthma. Expert Rev Respir Med 2012;6:441-9.
27. Wang Q, Yu C, Sun Y. The association between asthma and Helicobacter pylori: a meta-analysis. Helicobacter 2013;18:41-53.
28. Zhou X, Wu J, Zhang G. Association between Helicobacter pylori and asthma: a meta-analysis. Eur J Gastroenterol Hepatol 2013;25:460-8.